SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-18-000920
Filing Date
2018-08-09
Accepted
2018-08-09 18:32:13
Documents
1
Period of Report
2018-08-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 5441
  Complete submission text file 0001123292-18-000920.txt   7416
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Issuer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 HARTOM STREET, 2ND FLOOR, HAR HOTZVIM JERUSALEM L3 9777507
Business Address 7 HARTOM STREET, 2ND FLOOR, HAR HOTZVIM JERUSALEM L3 9777507 972 52 6130910
Antibody Investments LLC (Reporting) CIK: 0001749340 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38624 | Film No.: 181006673

Mailing Address 7 HARTOM STREET, 2ND FLOOR, HAR HOTZVIM JERUSALEM L3 9777507
Business Address
Shumacher Michael (Reporting) CIK: 0001749366 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38624 | Film No.: 181006674